Building on these advances, liraglutide represented a significant step forward as a synthetic human GLP-1RA approved for both T2DM (Tamborlane et al., 2019) and obesity (Feinglos et al., 2005
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes
While safety was established, efficacy for weight loss did not meet clinical trial success criteria
WATCH FULL VIDEO HERE: Dont forget to subscribe to Lifestyle Dentist for more science-based health, wealth, and lifestyle freedom insights
semaglutide)
In addition to diabetes treatment, the function of metformin also can be anti-aging, antiviral, and anti-inflammatory